ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 120,80
-0,94%
Dow Jones
42 801,72
0,52%
DAX
23 008,94
-1,87%
Brent Oil
69,965
-0,38%
Bitcoin
81 169,47
-5,79%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. Cara Therapeutics Inc (CARA) Cours

Cara Therapeutics Inc

Cara Therapeutics Inc (CARA)

NASDAQ
4,92
0,08
(1,65%)
Fermé 09 Mars 9:00PM
Retardé de 15 minutes
4,92
0,00
(0,00%)
Après les heures de négociation: 11:54PM
Retardé de 15 minutes

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Premium

Statistiques et détails clés

Dernier
4,92
Prix Achat
3,00
Prix Vente
5,35
Volume échangé
13 339
4,82 Fourchette du Jour 4,95
2,7084 Plage de 52 semaines 13,20
Cap du marché
22,491M
Clôture Veille
4,84
Ouverture
4,82
Dernière Transaction
10
@
5.09
Dernière heure de transaction
Volume financier
US$ 65 539
VWAP
4,9134
Volume moyen (3 m)
1 277 371
Actions en circulation
4 571 293
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-0,19
Bénéfice par action (BPA)
-25,93
Chiffre d'affairess
20,97M
Bénéfice net
-118,51M

À propos de Cara Therapeutics Inc

Cara Therapeutics Inc is an emerging biotechnology company involved in the development of novel therapeutics to treat human diseases associated with inflammation, pain, and pruritus. Cara's most advanced compound, CR845, aims to treat acute pain and pruritus. This patented compound has analgesic, an... Cara Therapeutics Inc is an emerging biotechnology company involved in the development of novel therapeutics to treat human diseases associated with inflammation, pain, and pruritus. Cara's most advanced compound, CR845, aims to treat acute pain and pruritus. This patented compound has analgesic, anti-inflammatory, and antipruritic properties that can be used for multiple therapeutic applications. Additionally, Cara's objective is to use its proprietary drug-screening technology to develop a future pipeline of first-in-class molecules with analgesic and anti-inflammatory features. Show more

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Site Web
www.caratherapeutics.com
Siège social
Wilmington, Delaware, USA
Fondé
-
Cara Therapeutics Inc est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker CARA. Le dernier cours de clôture d'Cara Therapeutics était de US$4,84. Au cours de la dernière année, les actions de Cara Therapeutics ont été négociées dans une fourchette de prix de US$ 2,7084 à US$ 13,20.

Cara Therapeutics compte actuellement 4 571 293 actions en circulation. La capitalisation boursière d'Cara Therapeutics est de US$22,13 million. Cara Therapeutics a un ratio cours/bénéfice (ratio PE) de -0.19.

CARA Dernières nouvelles

Plus de nouvelles

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
04 Mars 2025
CARA (1,65%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
04 Mars 2025
CARA (1,65%)

Form EFFECT - Notice of Effectiveness
Edgar (US Regulatory)
18 Février 2025
CARA (1,65%)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Edgar (US Regulatory)
14 Février 2025
CARA (1,65%)

Form S-4/A - Registration of securities, business combinations: [Amend]
Edgar (US Regulatory)
14 Février 2025
CARA (1,65%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
07 Février 2025
CARA (1,65%)

Form S-4/A - Registration of securities, business combinations: [Amend]
Edgar (US Regulatory)
27 Janvier 2025
CARA (1,65%)

Form 425 - Prospectuses and communications, business combinations
Edgar (US Regulatory)
21 Janvier 2025
CARA (1,65%)

Form 8-K - Current report
Edgar (US Regulatory)
21 Janvier 2025
CARA (1,65%)

Form 425 - Prospectuses and communications, business combinations
Edgar (US Regulatory)
17 Janvier 2025
CARA (1,65%)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10.173.578947368424.754.9954.3150984.60804944CS
4-0.09-1.796407185635.015.734.3161124.99771529CS
121.59648.01444043323.3246.362.708412773714.26859274CS
261.120829.50094756793.79926.362.70848584224.02607055CS
52-7.2-59.405940594112.1213.22.70847220344.81443593CS
156-123.24-96.1610486891128.16167.582.708470204342.77432566CS
260-163.68-97.0818505338168.6355.76762.7084712438104.0115803CS

CARA - Frequently Asked Questions (FAQ)

What is the current Cara Therapeutics share price?
The current share price of Cara Therapeutics is US$ 4,92
How many Cara Therapeutics shares are in issue?
Cara Therapeutics has 4 571 293 shares in issue
What is the market cap of Cara Therapeutics?
The market capitalisation of Cara Therapeutics is USD 22,13M
What is the 1 year trading range for Cara Therapeutics share price?
Cara Therapeutics has traded in the range of US$ 2,7084 to US$ 13,20 during the past year
What is the PE ratio of Cara Therapeutics?
The price to earnings ratio of Cara Therapeutics is -0,19
What is the cash to sales ratio of Cara Therapeutics?
The cash to sales ratio of Cara Therapeutics is 1,07
What is the reporting currency for Cara Therapeutics?
Cara Therapeutics reports financial results in USD
What is the latest annual turnover for Cara Therapeutics?
The latest annual turnover of Cara Therapeutics is USD 20,97M
What is the latest annual profit for Cara Therapeutics?
The latest annual profit of Cara Therapeutics is USD -118,51M
What is the registered address of Cara Therapeutics?
The registered address for Cara Therapeutics is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Cara Therapeutics website address?
The website address for Cara Therapeutics is www.caratherapeutics.com
Which industry sector does Cara Therapeutics operate in?
Cara Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
CAPSCapstone Holding Corp
US$ 3,50
(1 300,00%)
36,33k
ABLVAble View Global Inc
US$ 1,73
(137,18%)
5,13M
SUNESUNation Energy Inc
US$ 0,402999
(127,55%)
476,73M
BTOGBit Origin Ltd
US$ 0,6117
(118,46%)
618,03M
DWTXDogwood Therapeutics Inc
US$ 6,63
(49,66%)
25,77M
ALBTAvalon GloboCare Corporation
US$ 6,96
(-36,15%)
577,55k
SCNXScienture Holdings Inc
US$ 1,55
(-35,68%)
1,59M
ACXPAcurx Pharmaceuticals Inc
US$ 0,4572
(-29,88%)
1,18M
RETOReTo Eco Solutions Inc
US$ 5,42
(-27,73%)
108,27k
OCTOEightco Holdings Inc
US$ 1,08
(-27,03%)
336,99k
BTOGBit Origin Ltd
US$ 0,6117
(118,46%)
622,67M
SUNESUNation Energy Inc
US$ 0,402999
(127,55%)
482,05M
NVDANVIDIA Corporation
US$ 112,69
(1,92%)
341,94M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 10,675
(-0,70%)
143,04M
ICONIcon Energy Corporation
US$ 0,169898
(17,17%)
142,23M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
CARA
Cara Therapeutics
BIT
S29321
Societe Generale Effekten
BIT
S24976
SG ISSUER
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces